Standard BioTools Inc. (NASDAQ:LAB) Q2 2024 Earnings Call Transcript July 31, 2024
Standard BioTools Inc. misses on earnings expectations. Reported EPS is $-0.12279 EPS, expectations were $-0.06.
Operator: Good day and welcome to the Standard BioTools Second Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over David Holmes of Investor Relations....
